Binding is only the first hurdle
When you read about a new molecule, the headline is usually its affinity or potency — how tightly it grabs its target. That number is real and it matters. But a drug only works if the molecule actually arrives at the target in the body, in enough copies, for long enough. For a pill you swallow, that means dissolving in gut fluid, slipping across the intestinal wall, surviving the liver, and travelling in the blood. Every one of those steps is governed not by how well the molecule binds, but by its physical properties.
This is why experienced medicinal chemists talk about a compound's profile, not just its IC50. A molecule with weak solubility may never reach a useful concentration; one with poor permeability may sit in the gut and pass straight through. Good oral bioavailability is the product of many properties lining up at once.
The handful of properties that run the show
Remarkably, a small set of measurable numbers explains most of a small molecule's behaviour. You will meet each in detail later, but here is the cast: lipophilicity (how much the molecule prefers oil over water), pKa and ionization (whether it carries a charge at body pH), aqueous solubility, permeability, polar surface area, molecular weight, and the count of hydrogen-bond donors and acceptors.
What makes these so powerful is that they are not independent — they trade against each other in predictable ways. Add a greasy group to boost membrane crossing and you often hurt solubility. Add a polar group to dissolve better and you may lose permeability. The art of property-based design is steering through these trade-offs while keeping potency. The famous rule of five is simply an early, blunt summary of where most successful oral drugs have landed.
When a beautiful binder fails
A common and painful story: a screening campaign produces a hit with nanomolar potency, the team celebrates, and then the cell assay shows almost no effect. The molecule binds the isolated protein but cannot get inside a living cell, because it is too polar or too large to cross the membrane. The opposite story is just as common — a very greasy hit binds well and crosses membranes easily, but is so insoluble it crashes out of solution before it can be dosed.